[A benzoic acid derivative belonging to the meglitinide class of antidiabetic agents. Repaglinide blocks ATP-dependent potassium channels in pancreatic beta cells, thereby causing depolarization of the cell membrane and subsequent opening of calcium channels. The increased calcium influx into the pancreatic beta cells induces insulin secretion, thereby lowering blood glucose levels. ( NCI )]
UMLS (NCI) C0246689 - Organic Chemical
- Pharmacologic Substance
Relation/PAR: carbamate
Piperidines
[HS502] HYPOGLYCEMIC AGENTS, ORAL
Relation/CHD: REPAGLINIDE 1 MG
REPAGLINIDE 2 MG
REPAGLINIDE 0.5 MG